Exopharm (EX1) delivers positive results for potential erectile dysfunction treatment
- Exosome treatment researcher Exopharm (EX1) has found its Cevaris product to prove promising in treating erectile dysfunction
- Exosomes are small sacs created by cells which can deliver therapies to other cells
- The company wants to use exosomes to deliver stem cell therapies without the usual hassle
Positive results for potential erectile dysfunction treatment
Add TYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $23.95M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.3¢ | 2.1¢ | $20.30K | 917.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 294570 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.3¢ | 200000 | 1 |
View Market Depth
| Last trade - 15.39pm 10/06/2024 (20 minute delay) ? |
|
|||||
|
Last
2.2¢ |
Change
0.001 ( 4.76 %) |
||||
| Open | High | Low | Volume | ||
| 2.2¢ | 2.2¢ | 2.2¢ | 424904 | ||
| Last updated 11.31am 10/06/2024 ? | |||||
| TYP (ASX) Chart |